DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
SSCVX
Price
$21.33
Change
+$0.09 (+0.42%)
Updated
Jul 31 closing price
Net Assets
421.55M
Interact to see
Advertisement

DFSVX vs SSCVX

DFSVX vs SSCVX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. SSCVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and SSCVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. SSCVX (422M). DFSVX pays higher dividends than SSCVX: DFSVX (1.50) vs SSCVX (0.65). DFSVX was incepted earlier than SSCVX: DFSVX (33 years) vs SSCVX (29 years). SSCVX (1.29) is less costly to investors than DFSVX (0.31). SSCVX is a more actively managed with annual turnover of: 20.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than SSCVX: DFSVX (0) vs SSCVX (2000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. SSCVX (25.73). DFSVX return over 5 years is better than : 50.66 vs. SSCVX (0.75).
DFSVXSSCVXDFSVX / SSCVX
Total Expense Ratio0.311.2225%
Annual Report Gross Expense Ratio0.311.2924%
Fund Existence33 years29 years-
Gain YTD21.33627.87877%
Front LoadN/A6%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B422M4,621%
Annual Yield % from dividends1.500.65233%
Returns for 1 year34.3925.73134%
Returns for 3 years50.378.65583%
Returns for 5 years50.660.756,776%
Returns for 10 years107.7125.40424%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I